Insider

Carole Ho Insider Trading Activity

Every SEC Form 4 transaction reported by Carole Ho, sourced directly from SEC EDGAR and updated as new filings are accepted.

By · Insider-trading data from SEC EDGAR
Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Carole Ho buying or selling?

Carole Ho reported 0 open-market buys ($0) and 51 sells ($13.2M) across 51 Form 4 filings at 1 company — a net selling position of $13.2M.

Source: SEC EDGAR Form 4

What stands out

  • All 51 of Carole Ho's Form 4 filings are for one company, Denali Therapeutics Inc. (DNLI).
  • The most recent Form 4 was accepted on Aug 15, 2025 (14 months ago).
  • No open-market purchases or sales were reported in the last 12 months.

Key Statistics (as of Aug 15, 2025)

Total Form 4 filings
51
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (51)
$13.2M

Insider sentiment

Net selling

Net insider flow of $13.2M in net selling, filed between Aug 31, 2018 – Aug 15, 2025.

Companies Carole Ho files for

#CompanyForm 4 filings
1DNLIDenali Therapeutics Inc.51

Recent Carole Ho transactions

DateTickerRoleTypeSharesValueFiling
Aug 15, 2025DNLIChief Medical OfficerSale3.7K$51.7KSEC ↗
Jan 9, 2025DNLIChief Medical OfficerSale15.2K$308.3KSEC ↗
Aug 22, 2024DNLIChief Medical OfficerSale22.5K$549.9KSEC ↗
Aug 15, 2024DNLIChief Medical OfficerSale2.3K$53.5KSEC ↗
Feb 16, 2024DNLIChief Medical OfficerSale4.2K$73.1KSEC ↗
Jan 13, 2024DNLIChief Medical OfficerSale4.7K$88.8KSEC ↗
Jan 10, 2024DNLIChief Medical OfficerSale10.0K$193.8KSEC ↗
Aug 25, 2023DNLIChief Medical OfficerSale2.5K$58.6KSEC ↗
Aug 23, 2023DNLIChief Medical OfficerSale2.5K$56.0KSEC ↗
Aug 16, 2023DNLIChief Medical OfficerSale2.8K$65.9KSEC ↗
Aug 14, 2023DNLIChief Medical OfficerSale2.9K$69.0KSEC ↗
Feb 17, 2023DNLIChief Medical OfficerSale1.5K$43.4KSEC ↗
Feb 15, 2023DNLIChief Medical OfficerSale3.4K$101.1KSEC ↗
Feb 10, 2023DNLIChief Medical OfficerSale1.5K$47.0KSEC ↗
Jan 10, 2023DNLIChief Medical OfficerSale1.5K$41.6KSEC ↗
Jan 10, 2023DNLIChief Medical OfficerSale4.1K$116.6KSEC ↗
Jan 6, 2023DNLIChief Medical OfficerSale2.9K$83.6KSEC ↗
Aug 25, 2022DNLIChief Medical OfficerSale2.4K$77.5KSEC ↗
Aug 23, 2022DNLIChief Medical OfficerSale2.6K$85.6KSEC ↗
Feb 15, 2022DNLIChief Medical OfficerSale2.9K$101.3KSEC ↗
Feb 11, 2022DNLIChief Medical OfficerSale1.4K$52.8KSEC ↗
Jan 7, 2022DNLIChief Medical OfficerSale2.8K$127.4KSEC ↗
Dec 8, 2021DNLIChief Medical OfficerSale1.5K$62.8KSEC ↗
Aug 25, 2021DNLIChief Medical OfficerSale6.1K$300.5KSEC ↗
Aug 24, 2021DNLIChief Medical OfficerSale2.5K$126.2KSEC ↗

Showing the 25 most recent filings of 51. Screen every filing.

Carole Ho insider trading FAQ

Is Carole Ho buying or selling?

Across 51 SEC Form 4 filings, Carole Ho reported 0 open-market purchases totaling $0 and 51 sales totaling $13.2M — a net selling position of $13.2M.

Which companies does Carole Ho file Form 4s for?

Carole Ho has reported insider transactions at 1 company, most often Denali Therapeutics Inc. (DNLI).

How far back does Carole Ho's filing history go?

Trabud holds Carole Ho's SEC Form 4 filings from Aug 31, 2018 – Aug 15, 2025, sourced directly from SEC EDGAR.

Where does Trabud get Carole Ho's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Learn

What is SEC Form 4?

The filing behind every transaction here

Guide

How to Track Insider Trading

A practical workflow for following Form 4 activity

Use Case

Insider Buying Signals

How investors read insider purchases

Track Carole Ho and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener